In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging

被引:189
作者
Issa, B [1 ]
机构
[1] Hull Royal Infirm, Kingston Upon Hull HU3 2JZ, N Humberside, England
关键词
diffusion-weighted echo-planar imaging; apparent diffusion coefficient; prostate; tumor;
D O I
10.1002/jmri.10139
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To measure for the first time the apparent diffusion coefficient (ADC) values in anatomical regions of the prostate for normal and patient groups, and to investigate its use as a differentiating parameter between healthy and malignant tissue within the patient group. Materials and Methods: Single-shot diffusion-weighted echo-planar imaging (DW-EPI) was used to measure the ADC in the prostate in normal (N = 7) and patient (N = 19) groups. The spin-echo images comprised 96 X 96 pixels (field of view of 16 cm, TR/TE = 4000/120 msec) with six b-factor values ranging from 64 to 786 seconds/mm(2). Results: The ADC values averaged over all patients in non-cancerous and malignant peripheral zone (PZ) tissues were 1.82 +/- 0.53 x 10(-3) (mean +/- SD) and 1.38 +/- 0.52 x 10(-3) mm(2)/second, respectively (P = 0.00045, N = 17, paired t-test). The ADC values were found to be higher in the non-cancerous PZ (1.88 +/- 0.48 x 10(-3)) than in healthy or benign prostatic hyperplasia central gland (BPH-CG) region (1.62 +/- 0.41 x 10(-3)). For the normal group, the mean values were 1.91 +/- 0.46 x 10(-3) and 1.63 +/- 0.30 x 10(-3) mm(2)/second for the PZ and CG, respectively (P = 0.011, N = 7). Significant overlap exists between individual values among all tissue types. Further-more, ADC values for the same tissue type showed no statistically significant difference between the two subject groups. Conclusion: ADC is quantified in the prostate using DW-EPI. Values are lower in cancerous than in healthy PZ in patients, and in BPH-CG than PZ in volunteers.
引用
收藏
页码:196 / 200
页数:5
相关论文
共 25 条
[1]   A GENERALIZED FORMULATION OF DIFFUSION EFFECTS IN MU-M RESOLUTION NUCLEAR MAGNETIC-RESONANCE IMAGING [J].
AHN, CB ;
CHO, ZH .
MEDICAL PHYSICS, 1989, 16 (01) :22-28
[2]  
Castillo M, 2001, AM J NEURORADIOL, V22, P60
[3]  
CATALONA WJ, 1991, COMPREHENSIVE TXB ON, V2, P1089
[4]  
Filippi CG, 2001, AM J NEURORADIOL, V22, P65
[5]   Diffusion-weighted NMR imaging: Application to experimental focal cerebral ischemia [J].
HoehnBerlage, M .
NMR IN BIOMEDICINE, 1995, 8 (7-8) :345-358
[6]  
ISSA B, 1998, P 6 ANN M ISMRM SYDN
[7]  
Karger J., 1988, Adv. Magn. Reson, V12, P1
[8]  
Khan T, 1989, RADIOLOGY, V173, P847
[9]   PERFUSION AND DIFFUSION MR IMAGING [J].
KING, MD ;
VANBRUGGEN, N ;
BUSZA, AL ;
HOUSEMAN, J ;
WILLIAMS, SR ;
GADIAN, DG .
MAGNETIC RESONANCE IN MEDICINE, 1992, 24 (02) :288-301
[10]   CITRATE AS AN IN-VIVO MARKER TO DISCRIMINATE PROSTATE-CANCER FROM BENIGN PROSTATIC HYPERPLASIA AND NORMAL PROSTATE PERIPHERAL ZONE - DETECTION VIA LOCALIZED PROTON SPECTROSCOPY [J].
KURHANEWICZ, J ;
VIGNERON, DB ;
NELSON, SJ ;
HRICAK, H ;
MACDONALD, JM ;
KONETY, B ;
NARAYAN, P .
UROLOGY, 1995, 45 (03) :459-466